13F filer · CIK 1511901
Broadfin Capital, LLC
New York, NY · filing since Q2 2013 · last filing Feb 14, 2020
Reported value
$746.8M
+$205.9M vs prior
Positions
40
New / sold out
12 / 16
Added / reduced
11 / 13
Turnover
34.4%
buys $305.0M · sells $221.2M
Top-10 weight
63.7%
Biggest buys vs Q3 2019
| Change | Security | Shares change | Change % | Est. trade value |
|---|---|---|---|---|
| New | ISHARES TRPUT | +800,000 | – | +$132.5M |
| New | STAAR SURGICAL CO | +462,118 | – | +$16.3M |
| Added | ALKERMES PLC | +784,500 | +315.1% | +$16.0M |
| Added | QUOTIENT LTD | +1,380,754 | +225.1% | +$13.1M |
| New | LANTHEUS HLDGS INC | +617,953 | – | +$12.7M |
| Added | NANOSTRING TECHNOLOGIES INC | +444,800 | +401.4% | +$12.4M |
| New | VAPOTHERM INC | +1,003,099 | – | +$12.2M |
| Added | VIEWRAY INC | +2,573,005 | +85.7% | +$10.9M |
| Added | LA JOLLA PHARMACEUTICAL CO | +2,506,224 | +1378.2% | +$9.8M |
| New | ALEXION PHARMACEUTICALS INC | +83,100 | – | +$9.0M |
13 more rows. Subscribe for $29/month to see every row, download the data and use the API.
Biggest sells vs Q3 2019
| Change | Security | Shares change | Change % | Est. trade value |
|---|---|---|---|---|
| Reduced | SPDR SERIES TRUSTPUT | -350,000 | -50.0% | $-33.3M |
| Reduced | IOVANCE BIOTHERAPEUTICS INC | -597,800 | -52.9% | $-16.5M |
| Sold out | ALLERGAN PLC | -96,504 | -100.0% | $-16.2M |
| Reduced | AVADEL PHARMACEUTICALS PLC | -2,073,661 | -66.8% | $-15.7M |
| Sold out | MIRATI THERAPEUTICS INCCALL | -200,000 | -100.0% | $-15.6M |
| Sold out | NEVRO CORP | -150,510 | -100.0% | $-12.9M |
| Sold out | WRIGHT MED GROUP N V | -618,500 | -100.0% | $-12.8M |
| Sold out | ABBVIE INC | -154,500 | -100.0% | $-11.7M |
| Reduced | AMARIN CORP PLC | -519,767 | -33.1% | $-11.1M |
| Sold out | GLOBAL BLOOD THERAPEUTICS IN | -177,016 | -100.0% | $-8.6M |
19 more rows. Subscribe for $29/month to see every row, download the data and use the API.
Estimated trade value = change in shares × this quarter's implied price. 13F filings show quarter-end positions, not individual trades.
Reported value by quarter
Holdings · Q4 2019
| # | Security | Shares | Value | Weight |
|---|---|---|---|---|
| 1 | SPYSPDR S&P 500 ETF TRPUT | 440,000 | $141.6M | 18.96% |
| 2 | ISHARES TRPUTRUSSELL 2000 ETF | 800,000 | $132.5M | 17.75% |
| 3 | SPDR SERIES TRUSTPUTS&P BIOTECH | 350,000 | $33.3M | 4.46% |
| 4 | BIOHAVEN PHARMACTL HLDG CO LCALLCOM | 600,000 | $32.7M | 4.37% |
| 5 | BIODELIVERY SCIENCES INTL INCOM | 4,300,066 | $27.2M | 3.64% |
| 6 | VIEWRAY INCCOM | 5,574,366 | $23.5M | 3.15% |
| 7 | AMARIN CORP PLCSPONS ADR NEW | 1,049,244 | $22.5M | 3.01% |
| 8 | BIOHAVEN PHARMACTL HLDG CO LCOM | 409,338 | $22.3M | 2.98% |
| 9 | ALKERMES PLCSHS | 1,033,500 | $21.1M | 2.82% |
| 10 | QUOTIENT LTDSHS | 1,994,183 | $19.0M | 2.54% |
30 more rows. Subscribe for $29/month to see every row, download the data and use the API.